We are live on ! Find out more
TGI

TRV GP III Portfolio holdings

AUM $6.14M
1-Year Est. Return 45.44%
This Fund
S&P 500
This Quarter Est. Return
+24.7%
1 Year Est. Return
+45.44%
3 Year Est. Return
+169.98%
5 Year Est. Return
+802.39%
10 Year Est. Return
–
AUM
$235M
AUM Growth
+$31.1M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
–
Closed
–

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VYGR icon
1
Voyager Therapeutics
VYGR
$189M
$174M 73.96%
6,391,176
– –
NTGN
2
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
$46.2M 19.63%
9,741,636
– –
JNCE
3
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$15.1M 6.42%
3,048,780
– –

Similar funds

TOPU
Trustees of Princeton University Princeton, New Jersey $7.77M AUM
FWM
Fiat Wealth Management Wayzata, Minnesota $7.9M AUM
SCM
Somerset Capital Management London, United Kingdom $8.12M AUM 21.3% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
GIP
General Industrial Partners London, United Kingdom $2.57M AUM
LCMP
Linse Capital Management PR San Juan, Puerto Rico $2.31M AUM
SCM
SevenOneSeven Capital Management Lancaster, Pennsylvania $2.17M AUM 8.67% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

TRV GP III's Q2 2019 Portfolio in Review

As of Q2 2019, TRV GP III held 3 positions worth $235M, up 15% from $204M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2019: portfolio turnover was 0%. TRV GP III opened no new positions and made no exits, leaving the 3-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • TRV GP III's ten largest holdings make up 100% of its $235M portfolio in Q2 2019.
  • TRV GP III opened 0 new positions and closed 0 in Q2 2019.
  • TRV GP III's portfolio value rose 15% quarter-over-quarter to $235M.

Based on TRV GP III's 13F filing for Q2 2019, filed 6 Aug 2019.